Tak 799
![]() |
- ₹18770.55 - ₹72570.8
- Product name: Tak 799
- CAS: 229005-80-5
- MF: C33H39N2O2.Cl
- MW: 531.136
- EINECS:
- MDL Number:MFCD05662319
- Synonyms:2H-Oyran-4-aminium, N-((4-(((6,7-dihydro-2-(4-methylphenyl)-5H-benzocyclohepten-8-yl)carbonyl)amino)phenyl)methyl)tetrahydro-N,N-dimethyl-;2H-Pyran-4-aminium, N,N-dimethyl-N-(4-(((2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl)carbonyl)amino)benzyl)tetrahydro-, chloride;N,N-Dimethyl-N-(4-(((2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl)carbonyl)amino)benzyl)tetrahydro-2H-pyran-4-aminium chloride;Tak 799;Takeda 779;TAK 799 ;TAK 779;N,N-Dimethyl-N-[4-[[[2-(4-methylphenyl)-6,7-dihydro-5H-benzohepten-8-yl]carbonyl]amino]benzyl]tetrahydro-2H-pyran-4-aminium chloride;TAK779;TAK 799;TAKEDA 779
2 prices
Selected condition:
Brand
- Sigma-Aldrich(India)
Package
- 5MG
- 25MG
- ManufacturerSigma-Aldrich(India)
- Product numberSML0911
- Product descriptionTAK-779 ≥98% (HPLC)
- Packaging5MG
- Price₹18770.55
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberSML0911
- Product descriptionTAK-779 ≥98% (HPLC)
- Packaging25MG
- Price₹72570.8
- Updated2022-06-14
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich(India) | SML0911 | TAK-779 ≥98% (HPLC) | 5MG | ₹18770.55 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | SML0911 | TAK-779 ≥98% (HPLC) | 25MG | ₹72570.8 | 2022-06-14 | Buy |
Properties
storage temp. :2-8°C
solubility :H2O: soluble3mg/mL, clear (warmed)
form :powder
color :white to beige
solubility :H2O: soluble3mg/mL, clear (warmed)
form :powder
color :white to beige
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|
Description
TAK-779 has been used to inhibit CC chemokine ligand 5 (CCL5)– C-C chemokine receptor type 5 (CCR5) interaction in vitro in natural killer (NK) cytotoxicity assay. It has also been used as a blocker of CCR5 to study its effects and to evaluate the opening of the Panx-1 channels on peripheral blood mononuclear cells (PBMCs) isolated from human immunodeficiency virus (HIV)-infected individuals.More related product prices
6-[(7S)-7-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthalenecarboxamide TAK-733 TAK875 TAK-632 TAK-960